1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOCRYST-1777BC-103, NCT00061880
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Any age Sponsor: Pharmaceutical / Industry Protocol IDs: BCX1777-Bi-04-106, NCT00289562
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: Any age Sponsor: Pharmaceutical / Industry Protocol IDs: BIOCRYST-BCX1777-T-04-201, NCT00095381, UCLA-0404017-01
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BCX1777-Bo-05-204, NCT00289549
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BCX1777-203, BIOCRYST-BCX1777-203, NCT00501735
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BCX1777-210, NCT00640523
|
|
7.
|
Phase: Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOCRYST-1777BC-102, NCT00066235
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOCRYST-1777BC-101, CCF-5909, NCT00073944
|
|
9.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOCRYST-BCX1777-C-04-105, NCT00098332
|
|
10.
|
Phase: Phase I Type: Treatment Status: Closed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BCX1777-J01, NCT00823355
|